Aptevo Therapeutics Inc.
Status: Publicly traded
Direct answer
Aptevo Therapeutics Inc. is publicly traded on NASDAQ under the ticker APVO.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes. Beyond its lead asset,...
Can you invest in Aptevo Therapeutics Inc.?
Yes. Aptevo Therapeutics Inc. trades publicly on NASDAQ as APVO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Aptevo Therapeutics Inc.
Detailed equity research is provided by MarketSnap.